A new AI model from Google DeepMind called AlphaGenome can predict how DNA mutations affect biological processes, helping pinpoint genes linked to diseases and speeding up drug discovery.

In the field of Regenerative Medicine, the preclinical and clinical research on multipotent adult stem cells, and in ...

If the Trump White House is serious about its push to make medicines more affordable, it should ensure CMS officials never make this mistake again.

A fast-aging fish is giving scientists a rare, accelerated look at how kidneys grow old—and how a common drug may slow that ...

By any economic measure, the Food and Drug Administration (FDA) is one of the most important regulatory bodies in the federal ...

Overall, the “Hidradenitis Suppuritiva Update 2026” session underscored a new treatment paradigm: HS care in 2026 requires early diagnosis, systemic screening, combination medical therapy, and ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...

In a real-world study, patients with psoriatic disease treated with an IL-17 targeted biologic and a GLP-1 agonist ...

A paper published in Biology Methods and Protocols, indicates that a new computational method may help researchers identify ...

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2025. The list includes several groundbreaking therapies that are expected to change the ...

Introduces BD Neopak™ Glass Prefillable Syringe production in Columbus, Nebraska The BD Neopak™ Glass Prefillable Syringe platform is purpose-built to meet the complex and evolving needs of biologics ...